Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine

被引:31
作者
Edwards, AD
Shekunov, BY [1 ]
Forbes, RT
Grossmann, JG
York, P
机构
[1] Univ Bradford, Sch Pharm, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
[2] Daresbury Lab, CLRC, Warrington, Cheshire, England
关键词
crystallization; nomenclature; physical stability; polymorphism;
D O I
10.1002/jps.1064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The thermodynamic status of alpha -carbamazepine has been clarified using equilibrium solubility measurements, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), heated X-ray powder diffraction (XRPD), and temperature-controlled X-ray scattering techniques. alpha -Carbamazepine is the least stable of the three well-characterized anhydrous polymorphs of carbamazepine at 25 degreesC. In addition, it was confirmed that alpha -carbamazepine undergoes an exothermic transition to gamma -carbamazepine at 130 degreesC. The novel technique of time-resolved simultaneous small- and wide-angle X-ray scattering has been successfully applied to monitor this transition in situ. It was concluded that alpha -carbamazepine has a monotropic relationship with gamma -carbamazepine. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association.
引用
收藏
页码:1106 / 1114
页数:9
相关论文
共 23 条
[1]   HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS [J].
BEHME, RJ ;
BROOKE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) :986-990
[2]  
BORKA L, 1992, PHARM ACTA HELV, V67, P231
[3]   Drug therapy - Antiepileptic drugs [J].
Brodie, MJ ;
Dichter, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :168-175
[4]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[5]   X-ray characterization of the triclinic polymorph of carbamazepine [J].
Ceolin, R ;
Toscani, S ;
Gardette, MF ;
Agafonov, VN ;
Dzyabchenko, AV ;
Bachet, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1062-1065
[6]   THERMAL-ANALYSIS AND CALORIMETRIC METHODS IN THE CHARACTERIZATION OF POLYMORPHS AND SOLVATES [J].
GIRON, D .
THERMOCHIMICA ACTA, 1995, 248 :1-59
[7]   PHARMACEUTICAL APPLICATIONS OF POLYMORPHISM [J].
HALEBLIAN, J ;
MCCRONE, W .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (08) :911-+
[8]  
Han J, 1998, Pharm Dev Technol, V3, P587, DOI 10.3109/10837459809028643
[9]   PHARMACOKINETICS AND DISSOLUTION OF 2 CRYSTALLINE FORMS OF CARBAMAZEPINE [J].
KAHELA, P ;
AALTONEN, R ;
LEWING, E ;
ANTTILA, M ;
KRISTOFFERSSON, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 14 (01) :103-112
[10]  
Kala H, 1986, ACTA PHARM TECHNOL, V32, P72